关于:23andMe公司客户数据安全泄露诉讼
In Re: 23andMe, Inc. Customer Data Security Breach Litigation

原始链接: https://www.23andmedatasettlement.com/

已与23andMe(现“Chrome”)就2023年网络攻击达成和解,该攻击影响了约640万美国客户。如果您在2023年5月1日至2023年10月1日期间是23andMe客户,并收到了数据泄露通知,您可能有资格获得赔偿。 这些赔偿包括潜在的现金支付——“特别索赔”最高可达10,000美元,“健康信息索赔”最高可达165美元,“法定现金索赔”约为100美元——以及五年免费的隐私与医疗防护+基因监测服务。 要获得现金支付(不包括健康信息索赔),您**必须在**2026年2月17日之前**提交索赔**。您也可以选择在2025年12月29日之前**退出**和解,或在同一日期**反对**和解。不采取任何行动仍会使您受到和解的约束,但仅能获得监测服务。 此案为*23andMe, Inc. 客户数据安全泄露诉讼*,目前在美国密苏里州东区破产法院审理中。

关于Hacker News的讨论集中在23andMe数据泄露和随后的和解方案(23andmedatasettlement.com)上。用户质疑和解方案的充分性——根据索赔金额从100美元到10,000美元不等,外加潜在的隐私监控——认为这并不能真正补偿受害者因敏感基因和健康信息被盗而遭受的损失。 许多人表达了沮丧,认为隐私的价值远远超过了拟议的赔偿金额。一些人想知道与23andMe用户有关联的人以及希望提交索赔的加拿大人是否有资格。分享了相关文章的链接,包括一篇详细介绍了英国监管机构对23andMe处以230万英镑罚款的文章,以及另一篇强调该公司有争议的说法,即受害者部分自负。 一个关键点是,鉴于23andMe目前的财务状况,实现完全赔偿的难度很大,一些人建议改而寻求个人索赔。这场对话凸显了接受有限和解与争取更大问责制之间的争论。
相关文章

原文

23andMe-HeroB (1).svg

 

The U.S. Bankruptcy Court has authorized this Settlement Website. This is not a lawyer solicitation. 

 

 

A Settlement has been reached with 23andMe, Inc. (now known as “Chrome”) in a class action lawsuit over a cyberattack announced by 23andMe on October 6, 2023, which resulted in the theft of Personal Information in its databases concerning approximately 6.4 million United States residents.

 

You are a Settlement Class Member if you (a) were a 23andMe customer at any time between May 1, 2023 through October 1, 2023; (b) resided in the U.S. during this time; and (c) received notice from 23andMe that your personal information was compromised. 
 

You may be eligible for a cash payment and other benefits from a class action settlement:

  • Up to $10,000 for Extraordinary Claims;
  • Up to $165 for Health Information Claims;
  • An estimated $100 for Statutory Cash Claims; and
  • 5 years of Privacy & Medical Shield + Genetic Monitoring

 

Important things to know:

  • The class notice for In re: 23andMe, Inc. Customer Data Security Breach Litigation, Case No. 24-md-03098-EMC, was originally filed in the United States District Court for the Northern District of California and is now pending in the United States Bankruptcy Court for the Eastern District of Missouri as In re: Chrome Holding Co., et al., Case No. 25-40976-357.*
  • If you take no action, you will still be bound by the Settlement. 
  • You must file a Claim to receive a cash payment and other benefits the Settlement provides. Health Information Claim payments will be sent to eligible Settlement Class Members once payment information is provided.
  • If you do not want to be bound by the Settlement, you may request exclusion (“Opt-Out”), unless you received an opportunity to opt out of the Settlement through the Bankruptcy Solicitation Materials.
  • Even if you object, you must file a Claim in order to receive a cash payment and other benefits. 
  • You should read this Settlement Website carefully and completely as it tells you what you can get from the Settlement with 23andMe (now known as “Chrome”). It also describes what your other options are.

 

Your Options

File a ClaimYou must submit a Claim to receive a cash payment (other than a Health Information Claim payment) and to pre-enroll in Privacy & Medical Shield + Genetic Monitoring.February 17, 2026
Opt-OutIf you did not file a proof of claim in the Bankruptcy Proceedings, and you do not want to be legally bound by the Settlement or receive any benefits from it, you must Opt-Out of the SettlementDecember 29, 2025
ObjectIf you are a Settlement Class Member, you may object to the Settlement if you do not like it or a portion of it. December 29, 2025
Do NothingIf you are a Settlement Class Member and you do nothing, you will not receive any cash reimbursement or statutory benefit to which you might be entitled under the Settlement. But you will retain the opportunity to participate in five years of Privacy & Medical Shield + Genetic Monitoring services. 

 

____________________________
 

*On July 27, 2025, the Bankruptcy Court in In re Chrome Holding Co. (f/k/a 23andMe Holding Co.), et al., Case No. 25-40976 (Bankr. E.D. Mo.) approved the sale of 23andMe Holding Co. and 23andMe, Inc.’s assets to TTAM Research Institute, which sale was completed on July 14, 2025.  After the completion of the sale, 23andMe Holding Co. and 23andMe, Inc. formally changed their legal names to Chrome Holding Co. and ChromeCo, Inc., respectively. For ease of reference, Chrome Holding Co. and ChromeCo, Inc. are collectively referenced herein as “23andMe”.   
 

联系我们 contact @ memedata.com